tiprankstipranks
Trending News
More News >
Bafna Pharmaceuticals Limited (IN:BAFNAPH)
:BAFNAPH
India Market

Bafna Pharmaceuticals Limited (BAFNAPH) Financial Statements

Compare
0 Followers

Bafna Pharmaceuticals Limited Financial Overview

Bafna Pharmaceuticals Limited's market cap is currently ₹1.81B. The company's EPS TTM is ₹1.816; its P/E ratio is 42.23; Bafna Pharmaceuticals Limited is scheduled to report earnings on February 14, 2025, and the estimated EPS forecast is ₹―. See an overview of income statement, balance sheet, and cash flow financials.
Mar 24Mar 23Mar 22Mar 21Mar 20
Income Statement
Total Revenue₹ 1.52B₹ 1.15B₹ 851.40M₹ 712.18M₹ 424.73M
Gross Profit₹ 455.58M₹ 387.56M₹ 338.55M₹ 257.62M₹ 154.49M
Operating Income₹ 237.66M₹ 117.72M₹ 66.41M₹ 61.46M₹ -19.75M
EBITDA₹ 146.34M₹ 189.88M₹ 115.03M₹ 106.24M₹ 13.90M
Net Income₹ 73.48M₹ 113.38M₹ 52.16M₹ 58.27M₹ -247.29M
Balance Sheet
Cash & Short-Term Investments₹ 13.96M₹ 78.10M₹ 194.00K₹ 7.48M₹ 81.85M
Total Assets₹ 1.48B₹ 1.30B₹ 902.44M₹ 864.66M₹ 713.13M
Total Debt₹ 243.89M₹ 229.24M₹ 90.43M₹ 157.86M₹ 30.18M
Net Debt₹ 229.93M₹ 151.14M₹ 90.23M₹ 150.38M₹ -51.68M
Total Liabilities₹ 668.43M₹ 561.29M₹ 273.64M₹ 296.95M₹ 201.17M
Stockholders' Equity₹ 808.39M₹ 734.55M₹ 628.80M₹ 567.71M₹ 511.15M
Cash Flow
Free Cash Flow₹ -63.63M₹ -32.66M₹ 4.91M₹ -197.04M₹ -357.38M
Operating Cash Flow₹ 94.85M₹ 49.52M₹ 80.32M₹ -136.09M₹ -343.09M
Investing Cash Flow₹ -150.54M₹ -74.92M₹ -54.39M₹ -53.45M₹ 327.75M
Financing Cash Flow₹ -8.45M₹ 101.77M₹ -42.23M₹ 122.80M₹ 73.01M
Currency in INR

Bafna Pharmaceuticals Limited Earnings and Revenue History

Bafna Pharmaceuticals Limited Debt to Assets

Bafna Pharmaceuticals Limited Cash Flow

Bafna Pharmaceuticals Limited Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis